4.92
price down icon1.80%   -0.09
pre-market  プレマーケット:  4.92  
loading
前日終値:
$5.01
開ける:
$4.86
24時間の取引高:
51,675
Relative Volume:
0.02
時価総額:
$9.40M
収益:
-
当期純損益:
$-5.73M
株価収益率:
-0.7511
EPS:
-6.55
ネットキャッシュフロー:
$-4.13M
1週間 パフォーマンス:
-18.68%
1か月 パフォーマンス:
+2.71%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$4.80
$5.37
1週間の範囲:
Value
$4.77
$6.26
52週間の値動き範囲:
Value
$1.62
$29.28

Dogwood Therapeutics Inc Stock (DWTX) Company Profile

Name
名前
Dogwood Therapeutics Inc
Name
セクター
Healthcare (1165)
Name
電話
(866) 620-8655
Name
住所
44 MILTON AVENUE, ALPHARETTA
Name
職員
4
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
DWTX's Discussions on Twitter

DWTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DWTX
Dogwood Therapeutics Inc
4.92 9.40M 0 -5.73M -4.13M -6.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Dogwood Therapeutics Inc (DWTX) 最新ニュース

pulisher
Apr 01, 2025

Dogwood Therapeutics Reports 2024 Financial Results and Strategic Progress - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Dogwood Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Dogwood Strengthens Balance Sheet with $24M Capital Actions as Halneuron Trial Progresses - Stock Titan

Mar 31, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics begins Phase 2b trial for neuropathic pain By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

DWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion Strengthens Balance Sheet… - Zacks Small Cap Research

Mar 18, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics Begins Dosing in Mid-Stage Study of Halneuron for Chemotherapy-Related Neuropathic Pain - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics begins Phase 2b trial for neuropathic pain - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics Announces Dosing of First Patient in - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Revolutionary Non-Addictive Pain Treatment Enters Critical Phase 2b Trial for Cancer Patients - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics announces pricing of $4.8 million offering - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics Launches Registered Direct Offering; Shares Plunge -March 13, 2025 at 09:40 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics secures $4.8 million in direct offering By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics secures $4.8 million in direct offering - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics Secures $4.8 Million in Direct Offering to Advance Halneuron® Phase 2b Trial and Fund Operations Through Q1 2026 - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics, Inc. Announces Pricing of $4.8 - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Secures Critical Funding for Revolutionary Pain Treatment: What's Next for Halneuron? - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics clears debt with equity swa By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics converts existing debt to equity -March 12, 2025 at 10:34 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics Strengthens Balance Sheet with Debt Conversion - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics clears debt with equity swa - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics Announces Debt-to-Equity Exchange with CK Life Sciences, Strengthening Financial Position for Clinical Trials - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward - Financial Post

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics, Inc. Announces Conversion of Existing - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Major Breakthrough: Dogwood Therapeutics Wipes Out All Debt as Top Investor Backs Pain Drug Future - StockTitan

Mar 12, 2025
pulisher
Mar 10, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 10, 2025
pulisher
Feb 27, 2025

Dogwood Therapeutics (DWTX) to Release Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 24, 2025

Dogwood Therapeutics Inc expected to post a loss of $1.41 a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 18, 2025

DWTX Stock Hits 52-Week High at $15.74 Amidst Strong Yearly Growth - MSN

Feb 18, 2025
pulisher
Feb 04, 2025

Closing Figures Unveiled: Dogwood Therapeutics Inc (DWTX) Gain 13.53, Closes at 14.18 - The Dwinnex

Feb 04, 2025
pulisher
Jan 28, 2025

Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Surge - MSN

Jan 28, 2025
pulisher
Jan 27, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Jan 27, 2025
pulisher
Jan 27, 2025

Stock market news: Planet Image International +132.83%, Akero Therapeutics +94.04% among top gainers during mid day trading - Business Upturn

Jan 27, 2025
pulisher
Jan 27, 2025

Stock market news: Planet Image International surged by 160.47% while Allakos is still declining by 80.30% during mid day trading - Business Upturn

Jan 27, 2025
pulisher
Jan 27, 2025

Dogwood Therapeutics : Corporate Presentation (DWTX Inc. Corporate Overview Q1 2025) - Marketscreener.com

Jan 27, 2025
pulisher
Jan 27, 2025

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 27, 2025
pulisher
Jan 24, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 24, 2025
pulisher
Jan 24, 2025

Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Su - Asianet Newsable

Jan 24, 2025
pulisher
Jan 24, 2025

Clinical trial published in Nature Medicine shows proof of concept of PAGE's Therapeutics approach - Yahoo Finance

Jan 24, 2025
pulisher
Jan 24, 2025

AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders - Yahoo Finance

Jan 24, 2025
pulisher
Jan 24, 2025

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 24, 2025
pulisher
Jan 23, 2025

Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Is This Breakthrough the Future of Pain Management? A New Hope is Here! - Slapenas

Jan 23, 2025
pulisher
Jan 23, 2025

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Stock market news: Dogwood Therapeutics +551.79%, CTRL Group +93.07% among top gainers during mid day trading - Business Upturn

Jan 23, 2025
pulisher
Jan 23, 2025

Stock market news: Chanson International Holdings declined by 83.97% while Dogwood Therapeutics surged by 387.32% during mid day trading - Business Upturn

Jan 23, 2025
pulisher
Jan 23, 2025

Alnylam Pharmaceuticals receives a prestigious "Tell Award" for business investment in Switzerland - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Stock market today: Diginex +152.27%, Vince Holding +115.96% among top gainers in early trading session - Business Upturn

Jan 23, 2025
pulisher
Jan 23, 2025

ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy - Yahoo Finance

Jan 23, 2025

Dogwood Therapeutics Inc (DWTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):